PreOmics logo — SETTING THE STANDARD FOR PROTEIN ANALYSIS

PreOmics

SETTING THE STANDARD FOR PROTEIN ANALYSIS

Founded 2016 Germany Germany 56 employees Series B Total: $16.85M Analytics, Biotechnology +1

General Information

Company Name PreOmics
Founded Year 2016
Location Germany Germany +1
Employees 56
Industries Analytics, Biotechnology, Productivity
Funding Stage Series B
Social

Get notified when PreOmics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About PreOmics

PreOmics, founded in 2016 and headquartered in Germany, has become a pivotal part of the Biognosys Group as of 2025. The company's slogan, "SETTING THE STANDARD FOR PROTEIN ANALYSIS," highlights its core focus on enhancing proteomics through innovation and high-performance solutions.

The Biognosys Group, which includes PreOmics, Biognosys, and biocrates, is leading the charge in multiomics, integrating cutting-edge consumables, software, and instruments. This synergy delivers seamless mass spectrometry workflows. Their vendor-neutral approach broadens compatibility across major platforms, driving open collaboration in the scientific community.

PreOmics received a Series B investment of €13.50M in January 2022, backed by Bruker Corp.. This support underscores a strong alignment with strategic growth in the analytics and biotechnology sectors, offering scalable and flexible business models that adapt to diverse laboratory needs.

Taxonomy: Proteomics, Mass Spectrometry, Multiomics, Metabolomics, Lipidomics, Consumables, Scientific Software, Research Tools, Vendor-neutral Solutions, CRO Services, Sample Preparation, Bioanalysis, LC-MS, Protein Analysis, Biotechnology Innovation

Services & Products

Sample preparation kits for proteins and peptides
Protein and peptide data analysis software
Automated sample preparation platforms
Liquid chromatography solutions

Target Customers

Research laboratories Biotechnology companies Academic institutions Pharmaceutical companies

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 1
Investor
01 Jan 2022
Series A •••••• 3
Investor Investor
•••• ••••
01 Dec 2018
Support Program •••••• 4 •••• •••• 01 Aug 2016

PreOmics Alternatives & Competitors

View All Alternatives
PreOmics vs
Vane
Vane Germany

Vane is a financial technology platform offering working capital solutions to fast growing tech and...

Private Equity
16 employees
Digital Media, Financial Services
PreOmics vs
CSP Group
CSP Group Germany

Qualitymanagement for tool and product testing, process data management, worker assistance and datab...

92 employees
Information Technology
PreOmics vs

Excellence in Supply Chain

1215 employees
Logistics, Supply Chain

FAQ About PreOmics

SETTING THE STANDARD FOR PROTEIN ANALYSIS
PreOmics was founded in 2016.
PreOmics is headquartered in Germany.
PreOmics operates in the following industries: Analytics, Biotechnology, Productivity.
PreOmics has approximately 56 employees.
PreOmics has completed 3 funding rounds, raising a total of $16.85M. The latest funding stage is Series B.
PreOmics offers: Sample preparation kits for proteins and peptides, Protein and peptide data analysis software, Automated sample preparation platforms, Liquid chromatography solutions.
Top alternatives and competitors to PreOmics include Vane, CSP Group, Ziegler Group, ORAFOL, MM Group. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PreOmics and Vane are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors PreOmics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy